Author/Authors :
Ghasemian Dizaj Mehr, Sedigheh Department of Obstetrics and Gynecology - School of Medicine - Urmia University of Medical Sciences, Urmia, Iran , Ayatollahi, Hale Solid tumor Research Center - School of Medicine - Urmia University of Medical Sciences, Urmia, Iran , Mohammadi, Afshin Department of Radiology - School of Medicine - Urmia University of Medical Sciences, Urmia, Iran , Gharebaghi, Naser Department of Infectious Disease - School of Medicine - Urmia University of Medical Sciences, Urmia, Iran , Rashidi Fakari, Farzaneh Student Research Committee - Department of Midwifery and Reproductive Health - School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran , Mohammadi Payandeh, Shila Department of Obstetrics and Gynecology - School of Medicine - Urmia University of Medical Sciences, Urmia, Iran , Nazari, Leila Department of Obstetrics and Gynecology - School of Medicine - Urmia University of Medical Sciences, Urmia, Iran
Abstract :
Introduction: Choriocarcinoma is a rare neoplasm, which is commonly treated with chemotherapy. However, in some cases, it is
managed by surgical intervention to save the patient’s life. Here, we present a rare case of uterine rupture associated with choriocarcinoma in a patient with COVID-19 infection.
Case Presentation: We present the case of a 34-year-old woman with choriocarcinoma, complicated by uterine rupture after the first course of chemotherapy, and concurrent COVID-19 infection. The patient underwent an emergency hysterectomy and survived after transferring to an isolated intensive care unit room.
Conclusions: During the COVID-19 pandemic, it is suggested to perform optimal surgery in theemergencysetting to prevent further complications.
